Physician profile
Christopher J Schmidt
NPI 1063667541
$3,188.45
in general payments reported to CMS, 2019-2025
21 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $214 · 2021: $401 · 2022: $509 · 2023: $563 · 2024: $885 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214 · Debt Forgiveness: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.86 |
| Debt Forgiveness | $571.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $613.58 | 2020-2025 | |
| Photonicare INC | $571.43 | 2024 | Otosight Middle Ear Scope |
| Galderma Laboratories, L.P. | $377.22 | 2019-2021 | |
| Glaxosmithkline, LLC. | $327.50 | 2021-2025 | Nucala |
| Aerin Medical INC. | $233.69 | 2020-2024 | |
| Integra Lifesciences Corporation | $181.96 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $181.67 | 2019-2023 | Grafix Pl, Collagenase Santyl |
| Regeneron Healthcare Solutions, INC. | $149.99 | 2020-2025 | Dupixent, Libtayo |
| Stryker Corporation | $117.00 | 2020-2025 | Audion Et Dilation System |
| Access Pro Medical, LLC | $112.01 | 2023 | Matriderm |
| Optinose US, INC. | $58.08 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $48.88 | 2023-2025 | Keytruda |
| Organogenesis INC. | $47.61 | 2020-2024 | Affinity |
| Inspire Medical Systems, INC. | $32.14 | 2024 | Inspire |
| Medtronic, INC. | $31.69 | 2024 | Propel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $26.88 | 2022 | |
| Oticon Medical, LLC | $20.30 | 2019 | |
| Acera Surgical, INC. | $18.58 | 2022 | |
| Intersect Ent, INC. | $18.11 | 2019 | |
| Acclarent, INC | $14.10 | 2020 | |
| Phathom Pharmaceuticals, INC. | $6.03 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.